Sign In
Buy MRVI
$6.07
-0.160 (-2.57%)
At Close: Aug 10, 2026
Maravai LifeSciences (NASDAQ:MRVI) Shares Gap Up After Insider Buying Activity
02:19am, Saturday, 15'th Nov 2025
Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI - Get Free Report)'s share price gapped up before the market opened on Friday after an insider bought additional shares in the company. The stock had
Maravai LifeSciences Announces November 2025 Investor Conference Schedule
08:00am, Monday, 10'th Nov 2025
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to participate in the
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2025 Earnings Call Transcript
11:26pm, Thursday, 06'th Nov 2025
Maravai LifeSciences Holdings, Inc. ( MRVI ) Q3 2025 Earnings Call November 6, 2025 5:00 PM EST Company Participants Debra Hart - Senior Director of Investor Relations Bernd Brust - CEO & Director Raj
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q3 Loss, Misses Revenue Estimates
07:16pm, Thursday, 06'th Nov 2025
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.02 per share a year a
Maravai LifeSciences Reports Third Quarter 2025 Financial Results
04:01pm, Thursday, 06'th Nov 2025
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported
MARAVAI INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Maravai Long-Term Stockholders
07:52am, Wednesday, 29'th Oct 2025
Allegedly, Maravai misstated revenue and overstated goodwill due to weak internal controls, causing a 22% stock drop after delaying its earnings report.
Maravai LifeSciences To Host Earnings Conference Call on Thursday, November 6, 2025
04:01pm, Wednesday, 22'nd Oct 2025
SAN DIEGO--(BUSINESS WIRE)--Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its th
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acqu
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options If you purchased or acquir
Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2025 Earnings Call Transcript
11:36pm, Monday, 11'th Aug 2025
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q2 2025 Earnings Conference Call August 11, 2025 5:00 PM ET Company Participants Bernd Brust - CEO & Director Debra Hart - Senior Director of Investo
Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Lags Revenue Estimates
08:01pm, Monday, 11'th Aug 2025
Maravai LifeSciences Holdings, Inc. (MRVI) came out with a quarterly loss of $0.08 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to break-even earnings per share a ye
Maravai LifeSciences Reports Second Quarter 2025 Financial Results
04:05pm, Monday, 11'th Aug 2025
Announced organizational restructuring and operating cost reduction initiatives targeting more than $50 million in annualized cost savings
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025
05:08pm, Monday, 28'th Jul 2025
SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Maravai (MRVI) To Contact Him Directly To Discuss Their Options
